
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $3.4M | $4.2M | $4.9M | |
Selling, General & Admin | -- | -- | $1.4M | $7.9M | $15.6M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | $4.9M | $12.1M | $20.6M | |
Operating Income | -- | -- | -$4.9M | -$12.1M | -$20.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$4.9M | -$12.1M | -$20.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $576K | $576K | $576K | |
Net Income to Company | -- | -- | -$5.4M | -$12.7M | -$21.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$5.4M | -$12.7M | -$21.1M | |
Basic EPS (Cont. Ops) | -- | -- | -$0.08 | -$0.18 | -$0.31 | |
Diluted EPS (Cont. Ops) | -- | -- | -$0.08 | -$0.18 | -$0.31 | |
Weighted Average Basic Share | -- | -- | $71.2M | $71.2M | $68.1M | |
Weighted Average Diluted Share | -- | -- | $71.2M | $71.2M | $68.1M | |
EBITDA | -- | -- | -$4.9M | -$12.1M | -$20.6M | |
EBIT | -- | -- | -$4.9M | -$12.1M | -$20.6M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -$4.9M | -$12.1M | -$20.6M | |
Operating Income (Adjusted) | -- | -- | -$4.9M | -$12.1M | -$20.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $1.3M | $3.1M | |
Selling, General & Admin | -- | -- | -- | $3.3M | $4.3M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | $4.7M | $7.5M | |
Operating Income | -- | -- | -- | -$4.7M | -$7.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$4.7M | -$7.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $144K | $264.2K | |
Net Income to Company | -- | -- | -- | -$4.8M | -$7.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$4.8M | -$7.7M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.07 | -$0.11 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.07 | -$0.11 | |
Weighted Average Basic Share | -- | -- | -- | $71.2M | $71.6M | |
Weighted Average Diluted Share | -- | -- | -- | $71.2M | $71.6M | |
EBITDA | -- | -- | -- | -$4.7M | -$7.5M | |
EBIT | -- | -- | -- | -$4.7M | -$7.5M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$4.7M | -$7.5M | |
Operating Income (Adjusted) | -- | -- | -- | -$4.7M | -$7.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $6.9M | |
Selling, General & Admin | -- | -- | -- | -- | $16.2M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | $23.1M | |
Operating Income | -- | -- | -- | -- | -$23.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -$23.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $816.5K | |
Net Income to Company | -- | -- | -- | -- | -$24M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$24M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$0.33 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$0.33 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -$23.1M | |
EBIT | -- | -- | -- | -- | -$23.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -$23.1M | |
Operating Income (Adjusted) | -- | -- | -- | -- | -$23.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $2.5M | $4.4M | |
Selling, General & Admin | -- | -- | -- | $6.8M | $9.5M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | $9.3M | $13.9M | |
Operating Income | -- | -- | -- | -$9.3M | -$13.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$9.3M | -$13.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $288K | $528.5K | |
Net Income to Company | -- | -- | -- | -$9.6M | -$14.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$9.6M | -$14.4M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.13 | -$0.20 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.13 | -$0.20 | |
Weighted Average Basic Share | -- | -- | -- | $142.5M | $143.1M | |
Weighted Average Diluted Share | -- | -- | -- | $142.5M | $143.1M | |
EBITDA | -- | -- | -- | -$9.3M | -$13.9M | |
EBIT | -- | -- | -- | -$9.3M | -$13.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$9.3M | -$13.9M | |
Operating Income (Adjusted) | -- | -- | -- | -$9.3M | -$13.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $110 | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | $8.3M | |
Prepaid Expenses | -- | -- | $2.7M | $7.7M | $2.7M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $2.7M | $7.7M | $11M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | $40M | $40M | $73.4M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | $42.7M | $47.7M | $84.4M | |
Accounts Payable | -- | -- | $92.3K | $1.3M | $3.7M | |
Accrued Expenses | -- | -- | $1.1M | $259.1K | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $5.8M | $21M | $32.7M | |
Long-Term Debt | -- | -- | -- | -- | $3.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $6.4M | $22.2M | $38.2M | |
Common Stock | -- | -- | $6.8K | $6.8K | $7.2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | $36.3M | $25.5M | $46.1M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $36.3M | $25.5M | $46.1M | |
Total Liabilities and Equity | -- | -- | $42.7M | $47.7M | $84.4M | |
Cash and Short Terms | -- | -- | -- | -- | $110 | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $110 | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | $15.3M | |
Prepaid Expenses | -- | -- | -- | -- | $2.7M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | -- | $18M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | $73.4M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | $91.4M | |
Accounts Payable | -- | -- | -- | -- | $7.7M | |
Accrued Expenses | -- | -- | -- | -- | $8.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | $49.7M | |
Long-Term Debt | -- | -- | -- | -- | $3.8M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $55.8M | |
Common Stock | -- | -- | -- | -- | $7.2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | $35.6M | |
Total Liabilities and Equity | -- | -- | -- | -- | $91.4M | |
Cash and Short Terms | -- | -- | -- | -- | $110 | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$5.4M | -$12.7M | -$21.1M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $2M | $7.5M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -$2.1M | |
Cash From Operations | -- | -- | -- | -- | $126.4K | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $3.8M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | $1.1M | |
Cash From Financing | -- | -- | -- | -- | $4.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | $110 | |
Ending Cash (CF) | -- | -- | -- | -- | $110 | |
Levered Free Cash Flow | -- | -- | -- | -- | -$4.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$4.8M | -$7.7M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $2M | $2.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -$957.9K | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | $110 | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | $110 | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -$24M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $3.9M | $7.8M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$9.6M | -$14.4M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | $3.9M | $3.9M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -$7.1M | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | $220 | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | $220 | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.